|
| |
| ENDOCRINE & METABOLIC SYSTEM > ANTIHYPERLIPIDAEMIC AGENTS |
|
|
|
|
| > |
HK Registration No. |
: |
HK-54635 |
|
|
|
|
| > |
Active Ingredients |
: |
Gemfibrozil |
|
|
|
|
| > |
Indication of Use |
: |
Primary prevention of CHD & MI in patients with hyperlipidaemias. |
|
|
| > |
Dosage |
: |
Adult: 900-1200mg daily as directed. Max: 1500mg daily. |
|
|
|
|
| > |
Legal Classification |
: |
PIS1S3 |
|
|
|
|
|
|
|
|
|
